Paradigm Biopharmaceuticals (ASX:PAR) - Key People

ASX:PAR · Directors, executives and key personnel · 12 month lookback

Paul John Rennie Current

Managing Director (Executive Chairman)

Mentioned in

Healthcare Wrap - Week 25 (15 June -> 19 June) 2026

20 June 2026

Paradigm Surpasses Target in Phase 3 Osteoarthritis Trial Enrolment

15 June 2026

Healthcare Wrap - Week 23 (1 June -> 5 June) 2026

6 June 2026

Paradigm Biopharma Raises $21.375 Million in Oversubscribed Share Purchase Plan

1 June 2026

+15 more articles →

Also Mentioned

People named in Paradigm Biopharmaceuticals (ASX:PAR) articles over the last 12 months, by frequency.

Simon White · 20 articles Donna Skerrett · 6 articles Amos Meltzer · 6 articles Matthew Fry · 4 articles Abby Macnish Niven · 2 articles Catherine Stapledon · 2 articles Sanjiv Puri · 2 articles Melanie Duiker · 2 articles Abby Macnish · 1 article Phillip Bloom · 1 article Jackie Quist · 1 article Marc Murphy · 1 article Helen Jentz · 1 article